| Jennifer Ann Kalich, MD | |
|
1025 Morehead Medical Dr, Ste 450, Charlotte, NC 28204-2963 | |
| (704) 446-7800 | |
| Not Available |
| Full Name | Jennifer Ann Kalich |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 24 Years |
| Location | 1025 Morehead Medical Dr, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619907599 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 200000478 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastover Obstetrics And Gynecology Associates Inc | 2769444207 | 16 |
News Archive
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced that the Phase 3 VELOUR clinical trial of aflibercept (VEGF Trap) in patients with metastatic colorectal cancer (mCRC) will continue to completion as planned, with no modifications due to efficacy or safety concerns. This decision is based on the recommendation of an Independent Data Monitoring Committee (IDMC) following a planned interim analysis.
All-cause mortality rates fall progressively among women aged 60–76 years the more children they have borne, show Australian study results.
A study by Canadian researchers Eva Lonn, M.D., of the Population Health Research Institute and McMaster University, Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada, and colleagues, has found from examining experimental and epidemiological data, that patients who took vitamin E supplements for 7 years did not significantly reduce their risk of cancer or cardiovascular events and some in fact had an increased risk of heart failure.
Attractive males release fewer sperm per mating to maximise their chances of producing offspring across a range of females, according to a new paper on the evolution of ejaculation strategies. The findings by researchers at UCL (University College London) and the University of Oxford suggest that, paradoxically, matings with attractive males may be less fertile than those with unattractive ones.
Delta Air Lines' (NYSE: DAL) annual "Breast Cancer One" employee survivor flight took place yesterday, kicking off the airline's month-long campaign to generate awareness and raise money for The Breast Cancer Research Foundation.
› Verified 4 days ago
| Entity Name | Eastover Obstetrics And Gynecology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518982768 PECOS PAC ID: 2769444207 Enrollment ID: O20041115000416 |
News Archive
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced that the Phase 3 VELOUR clinical trial of aflibercept (VEGF Trap) in patients with metastatic colorectal cancer (mCRC) will continue to completion as planned, with no modifications due to efficacy or safety concerns. This decision is based on the recommendation of an Independent Data Monitoring Committee (IDMC) following a planned interim analysis.
All-cause mortality rates fall progressively among women aged 60–76 years the more children they have borne, show Australian study results.
A study by Canadian researchers Eva Lonn, M.D., of the Population Health Research Institute and McMaster University, Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada, and colleagues, has found from examining experimental and epidemiological data, that patients who took vitamin E supplements for 7 years did not significantly reduce their risk of cancer or cardiovascular events and some in fact had an increased risk of heart failure.
Attractive males release fewer sperm per mating to maximise their chances of producing offspring across a range of females, according to a new paper on the evolution of ejaculation strategies. The findings by researchers at UCL (University College London) and the University of Oxford suggest that, paradoxically, matings with attractive males may be less fertile than those with unattractive ones.
Delta Air Lines' (NYSE: DAL) annual "Breast Cancer One" employee survivor flight took place yesterday, kicking off the airline's month-long campaign to generate awareness and raise money for The Breast Cancer Research Foundation.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Ann Kalich, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Jennifer Ann Kalich, MD 1025 Morehead Medical Dr, Ste 450, Charlotte, NC 28204-2963 Ph: (704) 446-7800 |
News Archive
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced that the Phase 3 VELOUR clinical trial of aflibercept (VEGF Trap) in patients with metastatic colorectal cancer (mCRC) will continue to completion as planned, with no modifications due to efficacy or safety concerns. This decision is based on the recommendation of an Independent Data Monitoring Committee (IDMC) following a planned interim analysis.
All-cause mortality rates fall progressively among women aged 60–76 years the more children they have borne, show Australian study results.
A study by Canadian researchers Eva Lonn, M.D., of the Population Health Research Institute and McMaster University, Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada, and colleagues, has found from examining experimental and epidemiological data, that patients who took vitamin E supplements for 7 years did not significantly reduce their risk of cancer or cardiovascular events and some in fact had an increased risk of heart failure.
Attractive males release fewer sperm per mating to maximise their chances of producing offspring across a range of females, according to a new paper on the evolution of ejaculation strategies. The findings by researchers at UCL (University College London) and the University of Oxford suggest that, paradoxically, matings with attractive males may be less fertile than those with unattractive ones.
Delta Air Lines' (NYSE: DAL) annual "Breast Cancer One" employee survivor flight took place yesterday, kicking off the airline's month-long campaign to generate awareness and raise money for The Breast Cancer Research Foundation.
› Verified 4 days ago
Jackie Alan Lucas, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1025 Morehead Medical Dr, Ste 450, Charlotte, NC 28204 Phone: 704-446-7800 | |
Lynn Amy Boardman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1350 S Kings Dr, Charlotte, NC 28207 Phone: 704-446-1544 | |
Dr. Simon Vivian Ward Iii, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1918 Randolph Rd, Suite 670, Charlotte, NC 28207 Phone: 704-384-1620 Fax: 704-384-1626 | |
Curtis Lee Flood, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6331 Carmel Rd Ste 102, Charlotte, NC 28226 Phone: 980-367-4363 Fax: 704-316-2558 | |
Grant Blanchard, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1350 S Kings Dr, Charlotte, NC 28207 Phone: 704-446-1544 | |
Roland Pixley, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1025 Morehead Medical Dr, Ste 400, Charlotte, NC 28204 Phone: 704-446-1700 | |
Katherine Elizabeth Akeley, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1350 S Kings Dr, Charlotte, NC 28207 Phone: 704-446-1544 |